The chemokine CCL2 is a strong chemoattractant for CCR2+ monocytes (57) and its overexpression was reported in progressing breast cancer (58), prostate cancer (59), oral squamous cell carcinoma (OSCC) (60), liver cancer (61), and colorectal cancer (CRC) (62). Here, CCL2 is linked to prostate cancer.